Cell MedX Corp
OTC:CMXC
Cell MedX Corp
OTC:CMXC
Price:
0.48
USD
1.27%
Market Closed
Market Cap:
$3.1m
Income Statement
Earnings Waterfall
Cell MedX Corp
Cell MedX Corp
Income Statement
Cell MedX Corp
Cell MedX Corp
Currency: USD
| May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
0
N/A
|
0
-20%
|
0
-11%
|
0
-7%
|
0
-89%
|
0
+110%
|
0
-1%
|
0
-28%
|
0
-40%
|
0
-11%
|
0
+5%
|
0
-4%
|
0
-50%
|
0
-19%
|
0
-87%
|
0
-76%
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Gross Profit |
0
N/A
|
0
-16%
|
0
-12%
|
0
-9%
|
0
-94%
|
0
+97%
|
0
-1%
|
0
-23%
|
0
-24%
|
0
-29%
|
0
-10%
|
0
+23%
|
0
-85%
|
0
+56%
|
0
-69%
|
(0)
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(1)
N/A
|
(1)
+4%
|
(1)
+12%
|
(1)
+10%
|
(1)
+14%
|
(1)
-92%
|
(1)
+1%
|
(1)
+4%
|
(1)
+46%
|
(1)
+13%
|
(1)
+7%
|
(1)
+1%
|
(0)
+17%
|
(0)
+21%
|
(0)
+25%
|
(0)
+18%
|
(0)
-24%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
+4%
|
(1)
+11%
|
(1)
+19%
|
(1)
-21%
|
(2)
-67%
|
(2)
+1%
|
(1)
+4%
|
(1)
+52%
|
(1)
+12%
|
(1)
+5%
|
(1)
+0%
|
(0)
+14%
|
(0)
+16%
|
(0)
+20%
|
(0)
+71%
|
(0)
-47%
|
|
| Net Income | ||||||||||||||||||
| Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
+4%
|
(1)
+11%
|
(1)
+19%
|
(1)
-21%
|
(2)
-67%
|
(2)
+1%
|
(1)
+4%
|
(1)
+52%
|
(1)
+12%
|
(1)
+5%
|
(1)
+0%
|
(0)
+14%
|
(0)
+16%
|
(0)
+20%
|
(0)
+71%
|
(0)
-47%
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.02
-100%
|
-0.03
-50%
|
-0.03
N/A
|
-0.02
+33%
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
0
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
